Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

2 trials in Phase 3/4

Results Transparency

67%

4 of 6 completed trials have results

Key Signals

4 with results

Enrollment Performance

Analytics

N/A

4(66.7%)

Phase 4

2(33.3%)

6Total

N/A(4)

Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT03771638Phase 4Completed

DOT Diary Mobile App for Pre-Exposure Prophylaxis Adherence in Young Men

Role: collaborator

NCT05789875Not ApplicableCompleted

Youth Ending the HIV Epidemic

Role: collaborator

NCT03387462Phase 4Completed

DOT Diary Optimization Pilot: A Pilot Study to Optimize the DOT Diary App to Measure PrEP Adherence

Role: collaborator

NCT03127358Not ApplicableCompleted

Smartphone Based aDOT Treatment With Fixed-Dose Elbasvir and Grazoprevir in PWIDs

Role: collaborator

NCT02243670Not ApplicableCompleted

Using Artificial Intelligence To Monitor Medication Adherence in Opioid Replacement Therapy

Role: lead

NCT02599259Not ApplicableCompleted

Using Artificial Intelligence to Measure and Optimize Adherence in Patients on Anticoagulation Therapy.

Role: lead

All 6 trials loaded